Document Detail


Clinical characteristics of primary, secondary and suspected secondary Raynaud's syndrome and diagnostic transition in the long-term follow-up. A retrospective study in 900 patients.
MedLine Citation:
PMID:  19003757     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: There have so far been only partial studies or studies in fairly small groups of Raynaud's patients to systematically analyse the clinical features, the beginning of first Raynaud's attacks, the interval between first Raynaud's attacks and the first clinical examination, the duration of Raynaud's attacks, inducing factors, frequency of attacks, localization, coloration, accompanying symptoms, laboratory parameters, instrument-based examinational findings on the first examination, fitness for work, and development of the diagnostic classification in the long term. Such studies are, however, necessary for reasons of differential diagnostics and therapeutics. Patients and methods: The disease data of 900 patients with established Raynaud's symptoms, who underwent an examination between 1973 and 2002, were at first analysed in retrospect on the basis of their case history. This was followed, in 2002 to 2003, by a mail inquiry of all 900 patients, who were sent a comprehensive questionnaire to confirm history data and supplement clinical findings. Answers were received from 419 patients. In addition, 177 of the 900 patients underwent at least one follow-up examination after 2.8 years (1 month - 18 years), on the average, which allowed checking whether and how the diagnostic classification into primary, secondary and suspected secondary Raynaud's syndrome had changed. All data were analysed statistically. Results: Of the 900 patients, 77% were women and 23% were men. The mean age on the first examination was 45.1 +/- 15.5 years. Calculated on all patients, the first Raynaud's attacks occurred at the age of 39.5 +/- 16.9 years. The beginning of Raynaud's attacks fell mostly between the 21<sup>st</sup> and 60<sup>th</sup> year of life (minimum 3<sup>rd</sup> year, maximum 88<sup>th</sup> year). There was no statistical difference between primary, secondary and suspected secondary Raynaud's syndromes as to the time, ranging from 38.8 to 44.3 years of age, when the symptoms began. The duration of Raynaud's attacks averaged 23.6 +/- 23.5 min.; they occurred every day in 59.1%, once to three times a day in 26.8%, and more than three times a day in 31.1% of the cases. Factors inducing Raynaud's attacks were cold in 96.8% and stress in 19.2%. Raynaud's phenomenon was observed in both hands in 90.9% and in one hand only in 8.6% of the cases. A white discoloration only was observed in 39.0%, a white-blue discoloration sequence, in 19.3%, a purely blue discoloration, in 7.6%, and a triphasic colour response, in 19.1%. The latter sign was significantly more frequent in women and secondary Raynaud's syndrome than in men and primary Raynaud's syndrome. At 64.6%, secondary Raynaud's syndrome was significantly more often associated with pain than primary Raynaud's syndrome (47.9%). The mean systolic blood pressure was 125.6 +/- 20.9 mmHg, the mean diastolic pressure, 78.3 +/- 10.6 mmHg. Concomitant diseases were equally frequent in primary, secondary and suspected secondary Raynaud's syndrome. Finger, hand and arm artery occlusions were equally often seen in all three forms of Raynaud's syndrome. The results of the first examination showed that 72.9% of the 900 patients suffered from primary, 5.3% from secondary, and 21.3% from suspected secondary Raynaud's syndrome. In the long term, primary and suspected secondary Raynaud's syndromes showed a diagnostic transition in 19.2% of the cases after 2.8 years, on the average, while secondary Raynaud's syndromes did not. The clinical symptoms of the groups, as found on the first examination, were not altered by this transition, though. Conclusion: The clinical characteristics of Raynaud's syndromes (age when first Raynaud's attacks are observed, inducing factors of Raynaud's attacks, duration frequency of attacks, localization, coloration, and accompanying symptoms of an attack) are not specific and therefore not suitable to distinguish between primary and secondary Raynaud's syndrome. The case history, a general clinical examination, immunoserologic and capillaroscopic findings, and repeated examinations during 5 or more years are necessary to differentiate between primary, secondary and suspected secondary Raynaud's syndromes.
Authors:
H Heidrich; J Helmis; C Fahrig; R Hövelmann; N Martini
Related Documents :
1533117 - Evaluation of vectorelectrocardiographic analysis of young broiler chickens as a predic...
16001347 - Giant fold gastritis with consecutive gastric carcinoma in a patient with peutz-jeghers...
9875967 - Childhood vulval lichen sclerosus in a patient with ectodermal dysplasia and uncombable...
8291537 - De lange syndrome: a clinical review of 310 individuals.
23114677 - Recurrent horner syndrome and persistent trigeminal artery.
957377 - Ectrodactyly-ectodermal dysplasia-clefting (eec) syndrome: dominant inheritance and var...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  VASA. Zeitschrift für Gefässkrankheiten. Journal for vascular diseases     Volume:  37 Suppl 73     ISSN:  0301-1526     ISO Abbreviation:  VASA     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0317051     Medline TA:  Vasa     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  3-25     Citation Subset:  IM    
Affiliation:
Department of Medicine at the Free University of Berlin, Charité
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Capsule endoscopy findings in congenital afibrinogenemia-associated angiopathy.
Next Document:  The association of Raynaud's phenomenon/syndrome with scleroderma and Sjögren's syndrome - a meta-a...